Nuformix Limited
Records under this name other than the patents Nuformix Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 7 of 7 · Back to Nuformix Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,029,369 | Aprepitant L-Proline Composition and Cocrystal Formerly held In force · High confidence | In force | High confidence | |
| US 9,532,993 | Aprepitant L-proline solvates—compositions and cocrystals Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,822,066 | Tranilast compositions and cocrystals Lapsed on the fee record Ended Nov 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2025 | From the USPTO record |
| US 9,512,064 | Tranilast compositions and cocrystals Lapsed on the fee record Ended Dec 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 6, 2024 | From the USPTO record |
| US 9,248,196 | Rebamipide complexes and cocrystals Lapsed on the fee record Ended Feb 2, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 2, 2024 | From the USPTO record |
| US 8,871,793 | Metaxalone cocrystals Lapsed on the fee record Ended Oct 28, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2022 | From the USPTO record |
| US 8,779,146 | Cilostazol cocrystals and compositions Lapsed on the fee record Ended Jul 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2022 | From the USPTO record |